RPRX

NASDAQ · Pharmaceuticals

Royalty Pharma Plc- Cl A

Large-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks

$67.57

+0.01 (+0.01%)

As of Nov 5, 9:41 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target -46.3% upside

Low Target $26.65

Average Target $36.26

High Target $40.53

Current Price $67.57

Current
$67.57

Target
$36.26

$26.65 $36.26 avg $40.53

Scenario Analysis

Bear Case

$26.65

-60.6%

Low target

Base Case

$36.26

-46.3%

Avg target

Bull Case

$40.53

+-40.0%

High target

Risk/Reward

0.7x

Unfavorable

Price in Context

52-Week High

$66.29

1.9% from high

52-Week Low

$36.03

+87.6% from low

50-Day SMA

$60.59

+11.5% vs SMA

200-Day SMA

$53.63

+26.0% vs SMA

RSI (14)

83.1

Overbought

Target vs 52W High

$36.26

-45.3% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	36	86%	$1,330.33	-2.5%
RDY Dr. Reddy's Laboratories	Sell	42	45%	—	+0.0%
JNJ Johnson & Johnson	Buy	30	73%	$299.55	+10.0%
MRK Merck & Co. Inc.	Buy	35	74%	$159.27	+8.4%
PFE Pfizer Inc.	Hold	33	39%	$33.90	+13.5%
BMY Bristol-Myers Squibb Co	Hold	34	44%	$174.50	+176.4%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	14	93%	$36.26	-46.3%
ZTS Zoetis Inc	Hold	23	48%	$209.87	+155.6%